NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 156 filers reported holding NEVRO CORP in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $201,974 | -23.2% | 10,511 | +1.5% | 0.00% | – |
| Q2 2023 | $263,068 | -31.4% | 10,351 | -2.5% | 0.00% | -100.0% |
| Q1 2023 | $383,677 | -7.8% | 10,615 | +1.3% | 0.00% | 0.0% |
| Q4 2022 | $416,000 | +22.4% | 10,483 | +43.2% | 0.00% | 0.0% |
| Q3 2022 | $340,000 | -25.8% | 7,322 | -29.8% | 0.00% | 0.0% |
| Q2 2022 | $458,000 | -7.7% | 10,434 | +51.8% | 0.00% | 0.0% |
| Q1 2022 | $496,000 | -12.1% | 6,872 | -1.2% | 0.00% | 0.0% |
| Q4 2021 | $564,000 | -6.6% | 6,954 | +33.8% | 0.00% | 0.0% |
| Q3 2021 | $604,000 | -37.3% | 5,198 | -10.6% | 0.00% | -50.0% |
| Q2 2021 | $964,000 | +44.1% | 5,816 | +21.2% | 0.00% | 0.0% |
| Q1 2021 | $669,000 | -7.7% | 4,797 | +14.6% | 0.00% | 0.0% |
| Q4 2020 | $725,000 | +7.6% | 4,187 | -13.5% | 0.00% | 0.0% |
| Q3 2020 | $674,000 | +41.3% | 4,838 | +21.6% | 0.00% | 0.0% |
| Q2 2020 | $477,000 | +59.0% | 3,980 | +32.4% | 0.00% | +100.0% |
| Q1 2020 | $300,000 | – | 3,007 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BRAIDWELL LP | 1,776,368 | $34,141,793 | 1.08% |
| ARMISTICE CAPITAL, LLC | 3,456,000 | $66,424,320 | 1.02% |
| Palo Alto Investors LP | 386,832 | $7,434,911 | 0.70% |
| Rock Springs Capital Management LP | 1,211,600 | $23,286,952 | 0.62% |
| ArrowMark Colorado Holdings LLC | 2,468,110 | $47,437,074 | 0.58% |
| TD Capital Management LLC | 84,648 | $1,626,935 | 0.20% |
| Venator Management LLC | 25,000 | $480,500 | 0.18% |
| DAFNA Capital Management LLC | 28,000 | $538,160 | 0.17% |
| FRED ALGER MANAGEMENT, LLC | 1,053,812 | $20,254,266 | 0.12% |
| Counterpoint Mutual Funds LLC | 6,844 | $131,542 | 0.11% |